These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

912 related items for PubMed ID: 22740515

  • 21. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
    Gordon GJ, Mani M, Mukhopadhyay L, Dong L, Yeap BY, Sugarbaker DJ, Bueno R.
    J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597
    [Abstract] [Full Text] [Related]

  • 22. Involvement of Rad51 in cytotoxicity induced by epidermal growth factor receptor inhibitor (gefitinib, IressaR) and chemotherapeutic agents in human lung cancer cells.
    Ko JC, Ciou SC, Cheng CM, Wang LH, Hong JH, Jheng MY, Ling ST, Lin YW.
    Carcinogenesis; 2008 Jul; 29(7):1448-58. PubMed ID: 18544565
    [Abstract] [Full Text] [Related]

  • 23. Bcl-2 downregulation sensitizes nonsmall cell lung cancer cells to cisplatin, but not to docetaxel.
    Losert D, Pratscher B, Soutschek J, Geick A, Vornlocher HP, Müller M, Wacheck V.
    Anticancer Drugs; 2007 Aug; 18(7):755-61. PubMed ID: 17581297
    [Abstract] [Full Text] [Related]

  • 24. ICAM-3 enhances the migratory and invasive potential of human non-small cell lung cancer cells by inducing MMP-2 and MMP-9 via Akt and CREB.
    Park JK, Park SH, So K, Bae IH, Yoo YD, Um HD.
    Int J Oncol; 2010 Jan; 36(1):181-92. PubMed ID: 19956847
    [Abstract] [Full Text] [Related]

  • 25. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
    Li P, Wang K, Zhang J, Zhao L, Liang H, Shao C, Sutherland LC.
    Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
    [Abstract] [Full Text] [Related]

  • 26. A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.
    Yeh CT, Huang WC, Rao YK, Ye M, Lee WH, Wang LS, Tzeng DT, Wu CH, Shieh YS, Huang CY, Chen YJ, Hsiao M, Wu AT, Yang Z, Tzeng YM.
    Carcinogenesis; 2013 Dec; 34(12):2918-28. PubMed ID: 23880305
    [Abstract] [Full Text] [Related]

  • 27. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
    Yang L, Mashima T, Sato S, Mochizuki M, Sakamoto H, Yamori T, Oh-Hara T, Tsuruo T.
    Cancer Res; 2003 Feb 15; 63(4):831-7. PubMed ID: 12591734
    [Abstract] [Full Text] [Related]

  • 28. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
    Dalwadi H, Krysan K, Heuze-Vourc'h N, Dohadwala M, Elashoff D, Sharma S, Cacalano N, Lichtenstein A, Dubinett S.
    Clin Cancer Res; 2005 Nov 01; 11(21):7674-82. PubMed ID: 16278387
    [Abstract] [Full Text] [Related]

  • 29. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
    Azijli K, Yuvaraj S, van Roosmalen I, Flach K, Giovannetti E, Peters GJ, de Jong S, Kruyt FA.
    Apoptosis; 2013 Jul 01; 18(7):851-60. PubMed ID: 23456625
    [Abstract] [Full Text] [Related]

  • 30. Nitric oxide regulates c-fos expression in nucleus tractus solitarii induced by baroreceptor activation via cGMP-dependent protein kinase and cAMP response element-binding protein phosphorylation.
    Chan SH, Chang KF, Ou CC, Chan JY.
    Mol Pharmacol; 2004 Feb 01; 65(2):319-25. PubMed ID: 14742673
    [Abstract] [Full Text] [Related]

  • 31. The proteasome inhibitor PS-341 (bortezomib) up-regulates DR5 expression leading to induction of apoptosis and enhancement of TRAIL-induced apoptosis despite up-regulation of c-FLIP and survivin expression in human NSCLC cells.
    Liu X, Yue P, Chen S, Hu L, Lonial S, Khuri FR, Sun SY.
    Cancer Res; 2007 May 15; 67(10):4981-8. PubMed ID: 17510429
    [Abstract] [Full Text] [Related]

  • 32. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
    Fraser M, Chan SL, Chan SS, Fiscus RR, Tsang BK.
    Oncogene; 2006 Apr 06; 25(15):2203-12. PubMed ID: 16288207
    [Abstract] [Full Text] [Related]

  • 33. Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines.
    Fallahian F, Karami-Tehrani F, Salami S, Aghaei M.
    FEBS J; 2011 Sep 06; 278(18):3360-9. PubMed ID: 21777390
    [Abstract] [Full Text] [Related]

  • 34. The effects on cell growth and chemosensitivity by livin RNAi in non-small cell lung cancer.
    Yuan D, Liu L, Xu H, Gu D.
    Mol Cell Biochem; 2009 Jan 06; 320(1-2):133-40. PubMed ID: 18827979
    [Abstract] [Full Text] [Related]

  • 35. Sorafenib induces apoptotic cell death in human non-small cell lung cancer cells by down-regulating mammalian target of rapamycin (mTOR)-dependent survivin expression.
    Kim YS, Jin HO, Seo SK, Woo SH, Choe TB, An S, Hong SI, Lee SJ, Lee KH, Park IC.
    Biochem Pharmacol; 2011 Aug 01; 82(3):216-26. PubMed ID: 21601561
    [Abstract] [Full Text] [Related]

  • 36. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
    Qiu T, Zhou L, Wang T, Xu J, Wang J, Chen W, Zhou X, Huang Z, Zhu W, Shu Y, Liu P.
    Int J Mol Med; 2013 Sep 01; 32(3):593-8. PubMed ID: 23856992
    [Abstract] [Full Text] [Related]

  • 37. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt.
    Liu B, Shi ZL, Feng J, Tao HM.
    Cell Biol Int; 2008 May 01; 32(5):494-501. PubMed ID: 18078766
    [Abstract] [Full Text] [Related]

  • 38. Effects of shRNA-silenced livin and survivin on lung cancer cell proliferation and apoptosis.
    Zhao X, Yuan Y, Zhang Z, Feng X, Zhang J, Yuan X, Li J.
    J BUON; 2014 May 01; 19(3):757-62. PubMed ID: 25261663
    [Abstract] [Full Text] [Related]

  • 39. Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.
    Tirrò E, Consoli ML, Massimino M, Manzella L, Frasca F, Sciacca L, Vicari L, Stassi G, Messina L, Messina A, Vigneri P.
    Cancer Res; 2006 Apr 15; 66(8):4263-72. PubMed ID: 16618750
    [Abstract] [Full Text] [Related]

  • 40. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway.
    Xia Y, He Z, Liu B, Wang P, Chen Y.
    Mol Med Rep; 2015 Sep 15; 12(3):4530-4537. PubMed ID: 26059239
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 46.